IL17A and psoriasis: Down-regulation of IL-17A, IL-17F and IL-12B were detected as early as 2 weeks post-treatment with PF-06700841, suggesting the requirement of TYK2 and Janus kinase 1 for psoriasis signaling transduction (20).